Advisor Group, Inc. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$21,000
+5.0%
878
-18.5%
0.00%
Q3 2019$20,000
+100.0%
1,077
+111.6%
0.00%
Q2 2019$10,000
-71.4%
509
-64.1%
0.00%
Q1 2019$35,000
+84.2%
1,416
+96.4%
0.00%
Q4 2018$19,000
+137.5%
721
+185.0%
0.00%
Q3 2018$8,000
-20.0%
253
+2.8%
0.00%
Q2 2018$10,000
+42.9%
246
-2.0%
0.00%
Q1 2018$7,000
+600.0%
251
+434.0%
0.00%
Q4 2017$1,0000.0%47
+20.5%
0.00%
Q3 2017$1,0000.0%390.0%0.00%
Q2 2017$1,0000.0%390.0%0.00%
Q1 2017$1,0000.0%390.0%0.00%
Q4 2016$1,0000.0%39
-32.8%
0.00%
Q3 2016$1,00058
+205.3%
0.00%
Q2 2016$0190.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders